GLYCERIN - glycerin suppository 
Chain Drug Consortium LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Premier Value Pediatric Glycerin Supp

Active ingredient (in each suppository)

Glycerin 1 g

Purpose

Hyperosmotic laxative

Uses

Warnings

For rectal use only

May cause rectal discomfort of burning sensation

Ask a Doctor before using laxative if child has

  • abdominal pain, nausea or vomiting
  • a sudden change in bowel habits lasting more than two weeks
  • already used a laxative for more than 1 week

Stop use and consult a doctor if child has

  • rectal bleeding
  • no bowel movement within 1 hour of using this product

These symptoms may indicate a serious condition.

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Single daily dosage
children 2 to under 6 years1 suppository or as directed by a doctor
children under 2 yearsask a doctor

Insert suppository well up intorectum.

Suppository need not melt completely to produce laxative action.

Other information

Inactive ingredients

purified water, sodium hydroxide, stearic acid

Pediatric Glycerin Suppositories, 25 count

PremVal722.jpg

The product package shown above represents a sample of that currently in use. Additional packaging may also be available.

PediatricGlycerin Suppositories, 25 count

Distributed by Pharmacy Value Alliance, LLC

407 East Lancaster Avenue

Wayne, PA 19087

Premier Value Pediatric

GLYCERIN  
glycerin suppository
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68016-161
Route of AdministrationRECTAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN1 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68016-161-0025 in 1 JAR; Type 0: Not a Combination Product03/21/2012
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33403/21/2012
Labeler - Chain Drug Consortium LLC (101668460)
Registrant - DSC Laboratories, Inc. (097807374)
Establishment
NameAddressID/FEIBusiness Operations
DSC Laboratories, Inc.097807374manufacture(68016-161)

Revised: 11/2021
Document Id: cfe45419-be14-fdb6-e053-2995a90a4ce8
Set id: 022dd494-cb3c-4fa7-be99-4c38fabdc612
Version: 9
Effective Time: 20211103
 
Chain Drug Consortium LLC